Compounded versions of semaglutide, the active ingredient in ... or manufacturers other than the companies that make FDA-approved versions of the medicines, and they typically are allowed when ...
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief ...
is warning about potential risks from compounded versions of the drug semaglutide. Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and ...